Blue Crest Capital Management LTD Laboratory Corp Of America Holdings Transaction History

Blue Crest Capital Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$144.16 - $172.9 $427,146 - $512,302	-2,963 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$123.7 - $156.3 $366,523 - $463,116	2,963 New	2,963 $453,000
Q3 2018 Nov 14, 2018	SELL	$167.67 - $188.27 $307,171 - $344,910	-1,832 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$160.33 - $189.41 $293,724 - $346,999	1,832 New	1,832 $329,000
Q1 2018 May 15, 2018	SELL	$161.53 - $178.11 $17.8 Million - $19.7 Million	-110,467 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $16.3 Million - $18.1 Million	110,467	110,467 $17.6 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.